PLA2G5

Across TCGA pan-cancer cohorts, PLA2G5 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated PLA2G5 data layer compared with 25 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher PLA2G5 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PLA2G5 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

COAD, READ, and LUSC are the cancer types where PLA2G5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	III,IV	0.082	0.792	<.001	26	view →
READ	DFS	Median	All	0.162	0.720	.019	9	view →
LUSC	DFS	Median	All	0.143	0.797	<.001	7	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
UCEC	DFS	Median	All	1.000	0.630	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

PLA2G5–COAD (OS)

Open the COAD breakdown →